Private Equity
How GP Stakes Change the Alignment Picture for LPs and Managers
GP stakes deal activity hit record levels in 2025 while LP appetite for dedicated funds declined. One reason stands out: manager ownership structures are changing faster than the frameworks used to evaluate them.
Key Takeaways
GP stakes hit record volume in 2025, with deal count up 40%, while large LPs increasingly bypass dedicated funds to buy stakes directly. The management company itself has become the investment product.
The market is moving beyond minority stakes into outright control acquisitions of asset managers. LPs underwriting a fund managed by an acquired GP may be evaluating a different entity than the one they originally committed to.
The pro-stakes case is real: larger GP commitments, succession stability, operational resources. The counter is equally real: AUM-growth incentives, limited LP accountability, and structures built to minimize disclosure.
Managers who address post-stake ownership proactively shape the narrative. Those who treat it as resolved leave it to others.
A record market with a confidence problem
More GPs sold minority stakes in their management companies in 2025 than in any prior year. Campbell Lutyens recorded 164 transactions, a 40% increase over 2024, with total deal value reaching approximately $20 billion. 77% of GPs plan to do the same within two years. The supply side of this market is accelerating.
The demand side tells a different story. In 2026, combined LP commitment and interest in dedicated GP stakes funds are falling from 49% to 37% compared with the 2024 edition, looking “remarkably weak versus 2020-2022.” Even as 43% of LPs invest in GP stakes funds and 56% of those are considering direct stakes, appetite for the dedicated fund vehicles is softening.
Some of that is mechanical: LP over-allocation to alternatives, competition from secondaries and NAV lending, a migration from fund vehicles to direct transactions. But one dimension gets less attention than it warrants. The ownership structure of the firms LPs are underwriting has evolved, and the diligence frameworks most allocators rely on were not designed to capture that shift.
What changes when the management company becomes the asset
The structural tension in a GP stakes transaction is well understood in principle: the stakes investor's return depends on growing the management company's enterprise value, while the LP's return depends on fund-level performance. What is less well understood is where specifically those two interests pull apart, and how that divergence is playing out as the market scales.
The stakes investor benefits when a manager launches new products, grows AUM, and increases fee revenue. The LP benefits when the specific fund they committed to delivers strong returns. Both can happen simultaneously. Both can also pull in different directions, particularly when a manager faces pressure to scale faster than its investment edge supports.
Dechert's survey confirms the motivations are varied: North American GPs cite founder liquidity (50%) and succession planning (47%) as primary drivers. In APAC, 90% plan a divestiture in the next 24 months, up from 15% the prior year. No single narrative captures the market.
The market is also moving beyond minority stakes
The conversation tends to focus on minority stakes, but the market is already moving past that. In 2024 the majority of GP transactions were controlling strategic acquisitions rather than non-control stakes. US private equity acquired more asset managers in 2024 than in any prior year, with dealmaking increasingly crowding out dedicated GP stakes investors.
When a large asset manager acquires control of a GP rather than buying a minority stake, the governance and incentive structure shifts more fundamentally than any minority transaction implies. LPs underwriting a fund managed by an acquired GP are evaluating a different entity than the one they originally committed to.
Why smaller managers carry more of the weight
In 2025, 77.3% of PE fundraising dollars went to vehicles above $1 billion. For firms below that threshold, raising capital has become structurally harder, and stakes capital has shifted from strategic option to near-requirement for some. Sabina Comis, global co-managing partner of Dechert, noted: “At a time where it is harder to raise funds and LPs are asking for bigger GP commitments, stake sale proceeds can help GPs to finance their fund commitments.”
It also highlights a tension: the proceeds funding that larger commitment came from someone whose return depends on the management company growing, not on any single fund performing.
The institutionalization argument, taken seriously
The pro-stakes case rests on concrete mechanisms, not sentiment. Stakes capital can fund materially larger GP commitments. Christian von Schimmelmann of PACT Capital Partners stated that managers are using proceeds to move from 3% to 5% GP commitments: “It's so that they can make a stronger statement to their LPs about alignment.” For a $500 million fund, that shift puts an additional $10 million of the GP's own capital alongside LP money.
It also finances succession, builds infrastructure, and introduces resources that smaller firms would struggle to develop organically. It is estimated that AUM at firms completing stake sales increased by 84% in the first 10 years post-transaction. That figure reflects firms that self-selected into the strategy and likely overstates the broader effect, but the directional signal is consistent: stakes-backed firms tend to grow.
Large institutional investors are increasingly going direct rather than through dedicated funds. Temasek and Hunter Point Capital took a stake in Nuveen Private Capital. Mubadala, AXA IM, and Samsung Life bought into Hayfin Capital.
As Charles Korchinski of Eaton Partners put it: “This is a way for investors to be able to get exposure to highly profitable businesses that are growing at a pretty rapid clip.” This describes the management company as the investment, which is precisely the shift LPs in the underlying funds need to understand.
Where the alignment argument gets complicated
Experienced allocators hold the opposite view with equal conviction. One LP told PitchBook: “If one of our managers wants to do a GP stake, we always push back on it.” The concern: a GP stakes investor's thesis depends on the manager growing AUM, which can cause the GP to “value management fees over actual fund performance” and “rashly expand into new strategies, purely in the name of AUM growth.”
The concern has a legal foundation. Mayer Brown's April 2026 analysis and Lexology's review of GP stakes M&A both confirm that GP stakes investors are not fiduciaries to the fund's LPs. They hold governance rights, consultation privileges, and sometimes consent authority over strategic decisions, but they owe no formal duty to the investors whose capital sits in the underlying funds.
Several elements of the post-stake arrangement are not standard items in most LP-facing materials and tend to go unaddressed in investor relations processes:
Carry economics post-stake. The actual split, vesting schedule, and clawback terms after the transaction are infrequently disclosed in fund documents. The “smaller slice of a larger pie” framing is common; the underlying math usually is not.
Decision rights. Consent rights over fund sizing, strategy launches, and key hiring are active negotiation points. LPs rarely know which rights were retained and which were ceded.
Succession terms. Whether key-person refresh terms and vesting changed post-stake is directly relevant to LP risk and seldom volunteered.
The stakes investor's exit. The PE Law Report has covered the “looming threat of control transactions” as a live structuring concern. What happens at a control event, and whether LPs have any visibility, varies by deal.
Product expansion patterns. Whether a manager's post-stake strategy diversification tracks investment edge or AUM targets is observable through fund-by-fund performance attribution. Few allocators track it systematically.
How managers can get ahead of the conversation
GP stakes deals are often structured to avoid triggering LP consent or appearing in public disclosures. Mayer Brown titled its April 2026 analysis of LP communication in GP stakes transactions ‘the most important and often overlooked variable.” Many managers treat the transaction as resolved once proceeds are deployed. That leaves the alignment narrative to be shaped by whoever else is in the room.
Managers who have taken stakes capital
Proactive disclosure of the post-stake incentive architecture, even in summary form, signals confidence. Concretely: address the carry split, retained decision rights, and succession terms in investor materials with enough specificity that an investment committee member can evaluate alignment without guessing. It can help shorten diligence timelines rather than extending them.
Managers who have declined stakes capital
The absence of a stakes transaction can look like a missed window or a capital constraint rather than a deliberate posture. Managers who declined for alignment reasons have a positioning asset, but only if they articulate it. The reasoning belongs in the pitch and in LP conversations, framed around the specific alignment protections that founder ownership preserves.
Bottom line
As existing stakes mature, managers may seek to buy back stakes, trade them on the secondary market, or restructure ownership entirely. Each of those events creates a second alignment moment that is even less visible to LPs than the original transaction. Layer continuation vehicles, NAV lending, and GP financing on top, and multiple tiers of financial engineering now sit between allocators and the underlying investment.
The managers who build ownership transparency into their LP reporting before they are asked will hold a structural advantage as this market matures. Neither that shift nor the equivalent move on the allocator side, adding ownership structure to diligence alongside track record and terms, requires new regulation. Both are available now.
Collateral Partners works with fund managers to build investor materials that address the questions allocators are forming before they ask them. If your firm's ownership structure has changed, or if you are positioning against managers whose structure has, that belongs in your narrative, not outside it.
